ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

New Path Molecular Research Ltd

New Path Molecular Research Ltd is an active company incorporated on 29 January 2015 with the registered office located in Cambridge, Cambridgeshire. New Path Molecular Research Ltd was registered 10 years ago.
Status
Active
Active since incorporation
Company No
09412383
Private limited company
Age
10 years
Incorporated 29 January 2015
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 29 January 2025 (7 months ago)
Next confirmation dated 29 January 2026
Due by 12 February 2026 (5 months remaining)
Last change occurred 6 months ago
Accounts
Submitted
For period 1 Jun31 May 2024 (1 year)
Accounts type is Micro Entity
Next accounts for period 31 May 2025
Due by 28 February 2026 (5 months remaining)
Contact
Address
Building 580 Babraham Research Campus
Cambridge
Cambridgeshire
CB22 3AT
England
Same address for the past 7 years
Telephone
Unreported
Email
Unreported
People
Officers
5
Shareholders
30
Controllers (PSC)
1
Director • Scientist • British • Lives in UK • Born in Jan 1971
Director • British • Lives in England • Born in Nov 1964
Director • British • Lives in England • Born in Jun 1970
Director • British • Lives in UK • Born in Nov 1951
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Byzas Consultancy Limited
Mr Andrew Wilson Maccormack is a mutual person.
Active
Bees Abroad
Mr Andrew Wilson Maccormack is a mutual person.
Active
Arterius Limited
Deepbridge Ned Limited is a mutual person.
Active
Videregen Limited
Deepbridge Ned Limited is a mutual person.
Active
Marr-Munning Trust
Mr Andrew Wilson Maccormack is a mutual person.
Active
Fen Ep Limited
Deepbridge Ned Limited is a mutual person.
Active
Filisia Interfaces Ltd
Deepbridge Ned Limited is a mutual person.
Active
Trigenex Ltd
Deepbridge Ned Limited is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2016–2024)
Period Ended
31 May 2024
For period 31 May31 May 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
5
Decreased by 1 (-17%)
Total Assets
£449.36K
Increased by £245.05K (+120%)
Total Liabilities
-£168.49K
Increased by £76.94K (+84%)
Net Assets
£280.87K
Increased by £168.11K (+149%)
Debt Ratio (%)
37%
Decreased by 7.31% (-16%)
Latest Activity
Micro Accounts Submitted
6 Months Ago on 28 Feb 2025
Confirmation Submitted
6 Months Ago on 11 Feb 2025
Micro Accounts Submitted
1 Year 6 Months Ago on 27 Feb 2024
Deepbridge Ned Limited Appointed
1 Year 6 Months Ago on 13 Feb 2024
Paul Hedgeland Resigned
1 Year 6 Months Ago on 13 Feb 2024
Confirmation Submitted
1 Year 7 Months Ago on 9 Feb 2024
Micro Accounts Submitted
2 Years 6 Months Ago on 28 Feb 2023
Confirmation Submitted
2 Years 7 Months Ago on 9 Feb 2023
Micro Accounts Submitted
3 Years Ago on 25 Feb 2022
Confirmation Submitted
3 Years Ago on 9 Feb 2022
Get Credit Report
Discover New Path Molecular Research Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 3 August 2025
Submitted on 8 Aug 2025
Statement of capital following an allotment of shares on 30 May 2025
Submitted on 26 Jun 2025
Statement of capital following an allotment of shares on 3 April 2025
Submitted on 17 Apr 2025
Micro company accounts made up to 31 May 2024
Submitted on 28 Feb 2025
Confirmation statement made on 29 January 2025 with updates
Submitted on 11 Feb 2025
Statement of capital following an allotment of shares on 24 July 2024
Submitted on 20 Aug 2024
Statement of capital following an allotment of shares on 8 April 2024
Submitted on 2 May 2024
Statement of capital following an allotment of shares on 4 April 2024
Submitted on 2 May 2024
Second filing of a statement of capital following an allotment of shares on 5 March 2024
Submitted on 26 Apr 2024
Statement of capital following an allotment of shares on 5 March 2024
Submitted on 25 Mar 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year